The store will not work correctly when cookies are disabled.
2-(5-Benzyl-1H-[1,2,4]triazol-3-yl)-3-(5-nitro-thiophen-2-yl)-acrylonitrile
ID: ALA331583
PubChem CID: 11221402
Max Phase: Preclinical
Molecular Formula: C16H11N5O2S
Molecular Weight: 337.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1ccc([N+](=O)[O-])s1)c1n[nH]c(Cc2ccccc2)n1
Standard InChI: InChI=1S/C16H11N5O2S/c17-10-12(9-13-6-7-15(24-13)21(22)23)16-18-14(19-20-16)8-11-4-2-1-3-5-11/h1-7,9H,8H2,(H,18,19,20)/b12-9+
Standard InChI Key: FYFPLLFZVJBEJQ-FMIVXFBMSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
0.0917 -1.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3208 -2.4042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5250 -2.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2375 -2.9417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9167 -1.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4625 -1.0792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -2.8417 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.1250 -2.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2083 -1.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2167 -2.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3917 -2.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4500 -1.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2667 -0.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6167 -0.1167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6417 -1.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2250 -3.7667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9542 -2.5417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7458 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5250 -2.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6875 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1333 -3.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9208 -2.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4708 -1.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0958 -2.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 7 1 0
4 3 1 0
5 1 1 0
6 1 2 0
7 10 1 0
8 2 2 0
9 6 1 0
10 11 1 0
11 5 2 0
12 15 1 0
13 5 1 0
14 13 3 0
15 10 2 0
16 4 1 0
17 4 2 0
18 8 1 0
19 18 1 0
20 19 2 0
21 19 1 0
22 21 2 0
23 20 1 0
24 22 1 0
9 8 1 0
3 12 2 0
23 24 2 0
M CHG 2 4 1 16 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 337.36 | Molecular Weight (Monoisotopic): 337.0633 | AlogP: 3.43 | #Rotatable Bonds: 5 |
Polar Surface Area: 108.50 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.83 | CX Basic pKa: 0.72 | CX LogP: 4.60 | CX LogD: 4.59 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.44 | Np Likeness Score: -1.94 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |